Evaluation of the Efficacy and Adverse Reactions of Epirubicin Combined with Paclitaxel in the Treatment of Triple-negative Breast Cancer

WU Dan; QIN Boyu; QI Xiaoguang; QIN Yongcheng; HUANG Jiyi

doi:10.14033/j.cnki.cfmr.2020.13.002

Home>Articles>Evaluation of the Efficacy and Adverse Reactions of Epirubicin Combined with Paclitaxel in the Treatment of Triple-negative Breast Cancer

DOI: 10.14033/j.cnki.cfmr.2020.13.002

Evaluation of the Efficacy and Adverse Reactions of Epirubicin Combined with Paclitaxel in the Treatment of Triple-negative Breast Cancer

WU Dan

QIN Boyu

QI Xiaoguang

QIN Yongcheng

HUANG Jiyi

Machine-generated Keywords：

Publication Date：2020-05-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 5-7 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2020,18(13)